Skip to main content
Erschienen in: Clinical Drug Investigation 2/2000

01.06.2000 | Review Article

Dysmenorrhoea

Clinical Evidence with Piroxicam-β-Cyclodextrin

verfasst von: Dr M. Yusoff Dawood

Erschienen in: Clinical Drug Investigation | Sonderheft 2/2000

Einloggen, um Zugang zu erhalten

Abstract

Primary dysmenorrhoea can be readily relieved with nonsteroidal anti-inflammatory drugs (NSAIDs). These drugs inhibit prostaglandin synthetase, reducing the level of prostanoids in the uterus and the uterine contractions that cause the painful cramps. Piroxicam-β-cyclodextrin is rapidly absorbed and quickly reaches peak blood concentrations. Four published clinical studies have evaluated piroxicam-β-cyclodextrin for relief of primary dysmenorrhoea. Piroxicam-β-cyclodextrin 20mg once daily was significantly more effective than placebo in relief of dysmenorrhoea, was better than ketoprofen in relieving the abdominal pain of dysmenorrhoea, and had a quicker onset and longer duration of relief than naproxen. Both investigators and patients rated a greater preference for piroxicam-β-cyclodextrin over the comparator medications. The tolerability of piroxicam-β-cyclodextrin in the treatment of dysmenorrhoea was good, with a very low incidence of adverse effects.
Literatur
1.
Zurück zum Zitat Dawood MY. Dysmenorrhea. Infertil Reprod Med Clin North Am 1995; 6: 363–77 Dawood MY. Dysmenorrhea. Infertil Reprod Med Clin North Am 1995; 6: 363–77
2.
Zurück zum Zitat Heisterberg L. Factors influencing spontaneous abortion, dyspareunia, dysmenorrhea and pelvic pain. Obstet Gynecol 1993; 81: 594–7PubMed Heisterberg L. Factors influencing spontaneous abortion, dyspareunia, dysmenorrhea and pelvic pain. Obstet Gynecol 1993; 81: 594–7PubMed
3.
Zurück zum Zitat Bergsjo P, Jenssen H, Vellar OD. Dysmenorrhea in industrial workers. Acta Obstet Gynecol Scand 1975; 54: 255–9PubMedCrossRef Bergsjo P, Jenssen H, Vellar OD. Dysmenorrhea in industrial workers. Acta Obstet Gynecol Scand 1975; 54: 255–9PubMedCrossRef
4.
Zurück zum Zitat Dawood MY. Current concepts in the etiology and treatment of primary dysmenorrhea. Acta Obstet Gynecol Scand 1986; Suppl. 138: 7-10 Dawood MY. Current concepts in the etiology and treatment of primary dysmenorrhea. Acta Obstet Gynecol Scand 1986; Suppl. 138: 7-10
5.
Zurück zum Zitat Dawood MY. Overall approach to the management of dysmenorrhea. In: Dawood MY, McGuire JL, Demers LM, editors. Premenstrual syndrome and dysmenorrhea. Baltimore: Urban and Schwarzenberg, 1985: 177–204 Dawood MY. Overall approach to the management of dysmenorrhea. In: Dawood MY, McGuire JL, Demers LM, editors. Premenstrual syndrome and dysmenorrhea. Baltimore: Urban and Schwarzenberg, 1985: 177–204
6.
Zurück zum Zitat Costa S, Zinella G, Bufalino L. Piroxicam-β-cyclodextrin in the treatment of dysmenorrhoea. Drug Invest 1990; 2: 73–8CrossRef Costa S, Zinella G, Bufalino L. Piroxicam-β-cyclodextrin in the treatment of dysmenorrhoea. Drug Invest 1990; 2: 73–8CrossRef
7.
Zurück zum Zitat Woodcock BG, Acerbi D, Merz PG, et al. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man. Eur J Rheumatol Inflamm 1993; 12: 12–28PubMed Woodcock BG, Acerbi D, Merz PG, et al. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man. Eur J Rheumatol Inflamm 1993; 12: 12–28PubMed
8.
Zurück zum Zitat Zinelli G, Dessanti L, Ventura A, et al. Pharmacologic treatment of primary dysmenorrhoea: a controlled clinical study with piroxicam-beta-cyclodextrin complex. G Ital Obstet Ginecol 1986; 8: 679–87 Zinelli G, Dessanti L, Ventura A, et al. Pharmacologic treatment of primary dysmenorrhoea: a controlled clinical study with piroxicam-beta-cyclodextrin complex. G Ital Obstet Ginecol 1986; 8: 679–87
9.
Zurück zum Zitat Costa S, Mioli M, Ravaioli R, et al. Prostaglandin synthetase inhibitor piroxicam beta-cyclodextrin in the treatment of primary dysmenorrhea. Curr Ther Res 1987; 42: 156–64 Costa S, Mioli M, Ravaioli R, et al. Prostaglandin synthetase inhibitor piroxicam beta-cyclodextrin in the treatment of primary dysmenorrhea. Curr Ther Res 1987; 42: 156–64
10.
Zurück zum Zitat Gualdi F, Pagliani A, Dessanti L, et al. Tratamento della dismenorrhea primaria con el complesso piroxicam-beta-cyclodextrina. G Ital Obstet Ginecol 1989; 11: 77–82 Gualdi F, Pagliani A, Dessanti L, et al. Tratamento della dismenorrhea primaria con el complesso piroxicam-beta-cyclodextrina. G Ital Obstet Ginecol 1989; 11: 77–82
11.
Zurück zum Zitat Araujo JRA. Estudo da eficacia e seguranca do complexo-beta-ciclodextrina-piroxicam no tratamento da dismenorreia primaria. J Brasil Ginecol 1995; 105: 225–32 Araujo JRA. Estudo da eficacia e seguranca do complexo-beta-ciclodextrina-piroxicam no tratamento da dismenorreia primaria. J Brasil Ginecol 1995; 105: 225–32
12.
Zurück zum Zitat Santucci L, Fiorucci S, Chiucchiu S, et al. Placebo-controlled comparison of piroxicam-beta-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans. Dig Dis Sci 1992; 37: 1825–32PubMedCrossRef Santucci L, Fiorucci S, Chiucchiu S, et al. Placebo-controlled comparison of piroxicam-beta-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans. Dig Dis Sci 1992; 37: 1825–32PubMedCrossRef
Metadaten
Titel
Dysmenorrhoea
Clinical Evidence with Piroxicam-β-Cyclodextrin
verfasst von
Dr M. Yusoff Dawood
Publikationsdatum
01.06.2000
Verlag
Springer International Publishing
Erschienen in
Clinical Drug Investigation / Ausgabe Sonderheft 2/2000
Print ISSN: 1173-2563
Elektronische ISSN: 1179-1918
DOI
https://doi.org/10.2165/00044011-200019002-00006

Weitere Artikel der Sonderheft 2/2000

Clinical Drug Investigation 2/2000 Zur Ausgabe

Review Article

Dental Pain

Review Article

Postoperative Pain